Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

100.11USD
6 Mar 2015
Change (% chg)

$-2.41 (-2.35%)
Prev Close
$102.52
Open
$102.10
Day's High
$102.39
Day's Low
$99.88
Volume
2,643,296
Avg. Vol
2,687,621
52-wk High
$109.49
52-wk Low
$92.46

JNJ.N

Chart for JNJ.N

About

Johnson & Johnson is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies across the world. The Company’s primary focus has been on products related to human health and well-being.... (more)

Overall

Beta: 0.56
Market Cap(Mil.): $281,413.31
Shares Outstanding(Mil.): 2,780.49
Dividend: 0.70
Yield (%): 2.77

Financials

  JNJ.N Industry Sector
P/E (TTM): 17.75 38.98 40.20
EPS (TTM): 5.70 -- --
ROI: 15.32 17.01 16.34
ROE: 22.70 17.52 17.27
Search Stocks

AbbVie CEO defends Pharmacyclics deal to skeptical investors

NEW YORK - AbbVie Inc chief Richard Gonzalez fought two other drugmakers to "the bitter end" to buy Pharmacyclics Inc for its hot-selling Imbruvica cancer drug, but may have a harder time convincing investors it is worth $21 billion.

05 Mar 2015

Johnson & Johnson ordered to pay $5.7 million in California mesh trial

- A California jury on Thursday ordered Johnson & Johnson's Ethicon Inc unit to pay $5.7 million in the first trial over injuries blamed on the TVT Abbrevo, one of numerous transvaginal mesh products that are the subject of thousands of lawsuits.

05 Mar 2015

Johnson & Johnson ordered to pay $5.7 mln in California mesh trial

- A California jury on Thursday ordered Johnson & Johnson's Ethicon Inc unit to pay $5.7 million in the first trial over injuries blamed on the TVT Abbrevo, one of numerous transvaginal mesh products that are the subject of thousands of lawsuits.

05 Mar 2015

UPDATE 2-Johnson & Johnson ordered to pay $5.7 mln in California mesh trial

March 5 - A California jury on Thursday ordered Johnson & Johnson's Ethicon Inc unit to pay $5.7 million in the first trial over injuries blamed on the TVT Abbrevo, one of numerous transvaginal mesh products that are the subject of thousands of lawsuits.

05 Mar 2015

CORRECTED-Johnson & Johnson ordered to pay $5.6 mln in California mesh trial

March 5 - A California jury on Thursday ordered Johnson & Johnson's Ethicon Inc to pay $5.6 million in the first trial over injuries blamed on the TVT Abbrevo, one of numerous transvaginal mesh products that are the subject of thousands of lawsuits.

05 Mar 2015

J&J nearing deal to buy cancer drug maker Pharmacyclics: FT

- Johnson & Johnson is close to buying cancer drug maker Pharmacyclics Inc in the coming days, the Financial Times reported, citing sources.

04 Mar 2015

J&J nearing deal to buy cancer drug maker Pharmacyclics - FT

March 4 - Johnson & Johnson is close to buying cancer drug maker Pharmacyclics Inc in the coming days, the Financial Times reported, citing sources.

04 Mar 2015

BRIEF-J&J nearing deal to buy Pharmacyclics - FT

* Johnson & Johnson nearing deal to buy Pharmacyclics Inc - Financial Times Source text (http://on.ft.com/1EhbLrQ)

04 Mar 2015

Deals of the day- Mergers and acquisitions

March 2 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

02 Mar 2015

Cardinal to buy J&J vascular technology unit Cordis for $1.9 billion

NEW YORK - U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9 billion, completing its exit from the cardiovascular stent business.

02 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: GlobalData
$125.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks